Literature DB >> 25658247

Reopening of an obstructed third ventriculostomy: long-term success and factors affecting outcome in 215 infants.

Paul J Marano1, Scellig S D Stone, John Mugamba, Peter Ssenyonga, Ezra B Warf, Benjamin C Warf.   

Abstract

OBJECT: The role of reopening an obstructed endoscopic third ventriculostomy (ETV) as treatment for ETV failure is not well defined. The authors studied 215 children with ETV closure who underwent successful repeat ETV to determine the indications, long-term success, and factors affecting outcome.
METHODS: The authors retrospectively reviewed the CURE Children's Hospital of Uganda database from August 2001 through December 2012, identifying 215 children with failed ETV (with or without prior choroid plexus cauterization [CPC]) who underwent reopening of an obstructed ETV stoma. Treatment survival according to sex, age at first and second operation, time to failure of first operation, etiology of hydrocephalus, prior CPC, and mode of ETV obstruction (simple stoma closure, second membrane, or cisternal obstruction from arachnoid scarring) were assessed using the Kaplan-Meier survival method. Survival differences among groups were assessed using log-rank and Wilcoxon methods and a Cox proportional hazards model.
RESULTS: There were 125 boys and 90 girls with mean and median ages of 229 and 92 days, respectively, at the initial ETV. Mean and median ages at repeat ETV were 347 and 180 days, respectively. Postinfectious hydrocephalus (PIH) was the etiology in 126 patients, and nonpostinfectious hydrocephalus (NPIH) in 89. Overall estimated 7-year success for repeat ETV was 51%. Sex (p = 0.46, log-rank test; p = 0.54, Wilcoxon test), age (< vs > 6 months) at initial or repeat ETV (p = 0.08 initial, p = 0.13 repeat; log-rank test), and type of ETV obstruction (p = 0.61, log-rank test) did not affect outcome for repeat ETV (p values ≥ 0.05, Cox regression). Those with a longer time to failure of initial ETV (> 6 months 91%, 3-6 months 60%, < 3 months 42%, p < 0.01; log-rank test), postinfectious etiology (PIH 58% vs NPIH 42%, p = 0.02; log-rank and Wilcoxon tests) and prior CPC (p = 0.03, log-rank and Wilcoxon tests) had significantly better outcome.
CONCLUSIONS: Repeat ETV was successful in half of the patients overall, and was more successful in association with later failures, prior CPC, and PIH. Obstruction of the original ETV by secondary arachnoid scarring was not a negative prognostic factor, and should not discourage the surgeon from proceeding. Repeat ETV may be a more durable solution to failed ETV/CPC than shunt placement in this context, especially for failures at more than 3 months after the initial ETV. Some ETV closures may result from an inflammatory response that is less robust at the second operation.

Entities:  

Keywords:  Africa; CI = confidence interval; CPC = choroid plexus cauterization; CURE Children's Hospital of Uganda; ETV = endoscopic third ventriculostomy; HR = hazard ratio; NPIH = nonpostinfectious hydrocephalus; PIH = postinfectious hydrocephalus; children; choroid plexus cauterization; endoscopic third ventriculostomy; failure; hydrocephalus; outcome; repeat ETV

Mesh:

Year:  2015        PMID: 25658247     DOI: 10.3171/2014.10.PEDS14250

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  10 in total

1.  Endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC) for hydrocephalus of infancy: a technical review.

Authors:  Ian C Coulter; Michael C Dewan; Jignesh Tailor; George M Ibrahim; Abhaya V Kulkarni
Journal:  Childs Nerv Syst       Date:  2021-05-15       Impact factor: 1.475

2.  Surgeon interrater reliability in the endoscopic assessment of cistern scarring and aqueduct patency.

Authors:  Lucy He; Stephen Gannon; Chevis N Shannon; Brandon G Rocque; Jay Riva-Cambrin; Robert P Naftel
Journal:  J Neurosurg Pediatr       Date:  2016-05-27       Impact factor: 2.375

3.  Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda.

Authors:  Abhaya V Kulkarni; Steven J Schiff; Benjamin C Warf; Edith Mbabazi-Kabachelor; John Mugamba; Peter Ssenyonga; Ruth Donnelly; Jody Levenbach; Vishal Monga; Mallory Peterson; Michael MacDonald; Venkateswararao Cherukuri
Journal:  N Engl J Med       Date:  2017-12-21       Impact factor: 91.245

4.  Outcome of treatment after failed endoscopic third ventriculostomy (ETV) in infants with aqueductal stenosis: results from the International Infant Hydrocephalus Study (IIHS).

Authors:  Abhaya V Kulkarni; Spyros Sgouros; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2017-03-29       Impact factor: 1.475

Review 5.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 6.  Failure of Endoscopic Third Ventriculostomy.

Authors:  Jessica Lane; Syed Hassan A Akbari
Journal:  Cureus       Date:  2022-05-19

7.  Endoscopic third ventriculostomy revision after failure of initial endoscopic third ventriculostomy and choroid plexus cauterization.

Authors:  Anastasia Arynchyna-Smith; Curtis J Rozzelle; Hailey Jensen; Ron W Reeder; Abhaya V Kulkarni; Ian F Pollack; John C Wellons; Robert P Naftel; Eric M Jackson; William E Whitehead; Jonathan A Pindrik; David D Limbrick; Patrick J McDonald; Mandeep S Tamber; Brent R O'Neill; Jason S Hauptman; Mark D Krieger; Jason Chu; Tamara D Simon; Jay Riva-Cambrin; John R W Kestle; Brandon G Rocque
Journal:  J Neurosurg Pediatr       Date:  2022-04-22       Impact factor: 2.713

8.  The CURE Protocol: evaluation and external validation of a new public health strategy for treating paediatric hydrocephalus in low-resource settings.

Authors:  Jacob R Lepard; Michael C Dewan; Stephanie H Chen; Olufemi B Bankole; John Mugamba; Peter Ssenyonga; Abhaya V Kulkarni; Benjamin C Warf
Journal:  BMJ Glob Health       Date:  2020-02-23

9.  Brain growth after surgical treatment for infant postinfectious hydrocephalus in Sub-Saharan Africa: 2-year results of a randomized trial.

Authors:  Steven J Schiff; Abhaya V Kulkarni; Edith Mbabazi-Kabachelor; John Mugamba; Peter Ssenyonga; Ruth Donnelly; Jody Levenbach; Vishal Monga; Mallory Peterson; Venkateswararao Cherukuri; Benjamin C Warf
Journal:  J Neurosurg Pediatr       Date:  2021-07-09       Impact factor: 2.713

10.  Improving Infant Hydrocephalus Outcomes in Uganda: A Longitudinal Prospective Study Protocol for Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure after ETV/CPC.

Authors:  Taylor A Vadset; Ajay Rajaram; Chuan-Heng Hsiao; Miriah Kemigisha Katungi; Joshua Magombe; Marvin Seruwu; Brian Kaaya Nsubuga; Rutvi Vyas; Julia Tatz; Katharine Playter; Esther Nalule; Davis Natukwatsa; Moses Wabukoma; Luis E Neri Perez; Ronald Mulondo; Jennifer T Queally; Aaron Fenster; Abhaya V Kulkarni; Steven J Schiff; Patricia Ellen Grant; Edith Mbabazi Kabachelor; Benjamin C Warf; Jason D B Sutin; Pei-Yi Lin
Journal:  Metabolites       Date:  2022-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.